Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Quick Stats
Jun 23, 202649.3
AI Score
HOLD0.44
Volume Ratio
Aug 04, 2026
Next Earnings
11
+ve Days (30d)
18
-ve Days (30d)
RXRX Stock Summary
Last updated Jun 23, 2026
RXRX is currently trading at $3.1601, positioned below its 200-day moving average of $4.14, suggesting bearish momentum. The stock has a 52-week range of $2.77 to $7.18.
Technical Analysis: The 50-day moving average stands at $3.33, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 48.11, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.022, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates RXRX at 49.3/100 with a HOLD recommendation.
RXRX (Recursion Pharmaceuticals, Inc. Class A Common Stock) Indicators
Last updated Jun 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.11 |
| CMF (20) | -0.022 |
| ROC (10) | -3.614 |
| ADX (14) | 13.455 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.027 |
| AROONOSC (14) | -35.714 |
| WILLAMS %R (14) | -77.064 |
| MFI (14) | 35.271 |
RXRX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RXRX Price vs Max Options Open Interest
RXRX Max Change In Options Open Interest
RXRX Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RXRX Daily Out of Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RXRX Daily In the Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RXRX Most Active Options by Volume(near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Recursion Pharmaceuticals, Inc. Class A Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
RXRX Moving Averages Analysis
RXRX (Recursion Pharmaceuticals, Inc. Class A Common Stock) Simple Moving Averages
Moving Averages are last updated Jun 23, 2026
| Days | MA |
|---|---|
| 10 | 3.17 |
| 20 | 3.31 |
| 30 | 3.22 |
| 50 | 3.33 |
| 100 | 3.41 |
| 200 | 4.14 |
RXRX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.7 billion |
| Earnings/Share ($) | -1.16 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.9171 |
| EPS Estimate Next Year ($) | -0.8788 |
| WallStreet Target Price ($) | 6.6429 |
| Most Recent Quarter |